AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $389 | +20.8% | 5,560 | +23.9% | 0.00% | 0.0% |
| Q2 2023 | $322 | +49.1% | 4,487 | +60.0% | 0.00% | 0.0% |
| Q4 2022 | $216 | -99.9% | 2,805 | -51.0% | 0.00% | 0.0% |
| Q1 2022 | $237,000 | +3.5% | 5,722 | -5.4% | 0.00% | 0.0% |
| Q4 2021 | $229,000 | -67.8% | 6,049 | -42.6% | 0.00% | -66.7% |
| Q2 2021 | $711,000 | +25.2% | 10,540 | +5.0% | 0.00% | 0.0% |
| Q1 2021 | $568,000 | -30.0% | 10,040 | +0.9% | 0.00% | -25.0% |
| Q4 2020 | $811,000 | +18.0% | 9,955 | +3.2% | 0.00% | 0.0% |
| Q3 2020 | $687,000 | -22.5% | 9,643 | -10.5% | 0.00% | -33.3% |
| Q2 2020 | $886,000 | +80.1% | 10,772 | +28.9% | 0.01% | +50.0% |
| Q1 2020 | $492,000 | -78.7% | 8,356 | -62.6% | 0.00% | -73.3% |
| Q4 2019 | $2,311,000 | +301.2% | 22,360 | -21.5% | 0.02% | +275.0% |
| Q3 2019 | $576,000 | -18.8% | 28,475 | +3.5% | 0.00% | -20.0% |
| Q2 2019 | $709,000 | +183.6% | 27,525 | +56.6% | 0.01% | +150.0% |
| Q1 2019 | $250,000 | – | 17,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,123,929 | $42,462,000 | 36.04% |
| MORGAN JESS S & CO INC | 114,525 | $4,327,000 | 2.66% |
| Fairmount Funds Management LLC | 187,598 | $7,087,000 | 2.34% |
| WMS Partners, LLC | 242,500 | $9,162,000 | 1.95% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 610,064 | $23,048,000 | 1.41% |
| MANGROVE PARTNERS IM, LLC | 400,000 | $15,112,000 | 0.90% |
| RTW INVESTMENTS, LP | 1,618,819 | $61,159,000 | 0.89% |
| MPM BioImpact LLC | 103,405 | $3,907,000 | 0.71% |
| Avidity Partners Management LP | 775,000 | $29,280,000 | 0.62% |
| FIRST MIDWEST BANK TRUST DIVISION | 115,028 | $4,346,000 | 0.56% |